Roche Holding AG
A global leader in pharmaceuticals and diagnostics, pioneering personalized healthcare solutions.
RO | SW
Overview
Corporate Details
- ISIN(s):
- CH0012032048 (+1 more)
- LEI:
- 549300U41AUUVOAAOB37
- Country:
- Switzerland
- Address:
- Grenzacherstr. 124, 4058 Basel
- Website:
- https://www.roche.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Roche Holding AG is a global, research-based healthcare company operating through two primary divisions: Pharmaceuticals and Diagnostics. As one of the world's largest biotechnology companies, Roche is a leading provider of innovative cancer treatments and a key developer of medicines for viral infections and cardiometabolic diseases. The Diagnostics division focuses on providing in-vitro diagnostic tests and transformative solutions that support early detection, prevention, diagnosis, and treatment monitoring. By combining its strengths in both pharmaceuticals and diagnostics, Roche aims to advance personalized healthcare and improve patient outcomes worldwide through scientific innovation and digital health solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2004-12-31 00:00 |
Annual Report
Annual Report 2004
|
English | 8.5 MB | ||
| 2004-12-31 00:00 |
Annual Report
Jahresbericht 2004
|
German | 8.8 MB | ||
| 2004-04-22 00:00 |
Investor Presentation
Presentation to analysts
First Quarter 2004
Basle, April 21, 2004
|
English | 1.2 MB | ||
| 2003-12-31 00:00 |
Annual Report
Annual Report 2003
|
English | 8.4 MB | ||
| 2003-12-31 00:00 |
Annual Report
Jahresbericht 2003
|
German | 8.5 MB | ||
| 2003-07-25 00:00 |
Investor Presentation
First Half 2003
Presentation to analysts
|
English | 1.1 MB | ||
| 2003-04-11 00:00 |
Investor Presentation
26 March 2003Roadshow USANew York
|
English | 175.9 KB | ||
| 2003-04-10 00:00 |
Investor Presentation
Company Presentation 2003
|
English | 250.3 KB | ||
| 2003-02-12 00:00 |
Investor Presentation
16 January 2003 Roadshow Germany
|
English | 323.7 KB | ||
| 2002-12-31 00:00 |
Annual Report
Annual Report 2002
|
English | 9.3 MB | ||
| 2002-12-31 00:00 |
Annual Report
Jahresbericht 2002
|
German | 9.7 MB |
Automate Your Workflow. Get a real-time feed of all Roche Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Roche Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-16 | N/A | Executive member | Sell | None | 1,494,248.20 CHF |
| 2025-02-07 | N/A | Non-Executive member | Buy | None | 613,652.00 CHF |
| 2024-07-26 | N/A | Non-Executive member | Sell | None | 1,743,760.00 CHF |
| 2024-07-25 | N/A | Non-Executive member | Sell | None | 723,460.00 CHF |
| 2024-06-21 | N/A | Executive member | Sell | None | 2,220,432.00 CHF |
| 2024-06-10 | N/A | Executive member | Sell | None | 1,260,138.00 CHF |
| 2024-05-29 | N/A | Non-Executive member | Buy | None | 504,400.00 CHF |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
